Latest Breaking News On - Immunic inc nasdaq - Page 1 : comparemela.com

EQS-News: Immunic AG: Immunic to Participate in Industry and Scientific Conferences in June

Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible

Den haagZuid hollandUnited statesSan diegoJessica breuEdna kaplanWerner gladdinesPaula schwartzContract management groupRx communications groupDistribution servicesImmunic incInternational conventionExchange commissionImmunic inc nasdaqCommunications of immunic

EQS-News: Immunic AG: Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update

EQS-News: Immunic AG: Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittEdna kaplanJessica breuPaula schwartzTrademark officeExchange commissionImmunic inc nasdaqClinical development programsAmericas committee for treatmentDevelopment rd expensesImmunic incRx communications groupDistribution servicesResearch in multiple sclerosisInterim statement

EQS-News: Immunic, Inc : Immunic Highlights 2023 Accomplishments and Upcoming Milestones

EQS-News: Immunic, Inc : Immunic Highlights 2023 Accomplishments and Upcoming Milestones
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoPaula schwartzDaniel vittJessica breuRichard rudickEdna kaplanHella kohlhofExchange commissionJp morgan health care conferenceCorporate communityImmunic inc nasdaqProgram in relapsing multiple sclerosis ongoingInternational business gold awardDistribution servicesImmunic inc

Immunic (IMUX) Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium

Immunic (IMUX) Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJens kuhleDaniel vittAndreas muehlerImmunic inc nasdaqUniversity hospitalSclerosis centreSenior physicianNeuroimmunology unitMultiple sclerosis centreChief executive officerChief medical officer

Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

United statesPaula schwartzAndreas muehlerJessica breuDaniel vittEdna kaplanExchange commissionRx communications groupImmunic inc nasdaqImmunic incUnblinded interim biomarker analysis expectedFull data readout expectedChief executive officerChief medical officerNorth americaEastern europe